Xi Xu

1.2k total citations
50 papers, 947 citations indexed

About

Xi Xu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xi Xu has authored 50 papers receiving a total of 947 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 15 papers in Cancer Research and 12 papers in Oncology. Recurrent topics in Xi Xu's work include Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (5 papers) and Inflammatory Bowel Disease (5 papers). Xi Xu is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (5 papers) and Inflammatory Bowel Disease (5 papers). Xi Xu collaborates with scholars based in China, France and United States. Xi Xu's co-authors include Zhi Hua Ran, Jin Lu Tong, Shu Dong XIAO, Fang Nie, Ming Zhu, Mei Huang, Mingming Zhu, Qi Xu, Jun Shen and Yu Qiao and has published in prestigious journals such as PLoS ONE, Scientific Reports and FEBS Letters.

In The Last Decade

Xi Xu

47 papers receiving 937 citations

Peers

Xi Xu
Yisheng Pan China
Srinivas Chava United States
Wen Zhou China
Hongchun Liu China
Li Bao China
Yuqi He China
Dil Afroze India
Sung‐Chul Lim South Korea
Qian Ma China
Yisheng Pan China
Xi Xu
Citations per year, relative to Xi Xu Xi Xu (= 1×) peers Yisheng Pan

Countries citing papers authored by Xi Xu

Since Specialization
Citations

This map shows the geographic impact of Xi Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi Xu more than expected).

Fields of papers citing papers by Xi Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xi Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi Xu. The network helps show where Xi Xu may publish in the future.

Co-authorship network of co-authors of Xi Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xi Xu. A scholar is included among the top collaborators of Xi Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xi Xu. Xi Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Xi, et al.. (2025). Which Is the Best Biologic for Nasal Polyps: An Updated Network Meta‐Analysis. Clinical and Translational Allergy. 15(11). e70114–e70114.
2.
3.
Xu, Xi, Chaoju Gong, Yunfeng Wang, et al.. (2024). FOXF1 promotes ovarian cancer metastasis by facilitating HMGA2-mediated USP30-dependent S100A6 deubiquitination. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(3). 167633–167633.
4.
Xu, Xi, Hang Zhang, Haisheng Hao, et al.. (2023). Effects of β-Nicotinamide Mononucleotide, Berberine, and Cordycepin on Lipid Droplet Content and Developmental Ability of Vitrified Bovine Oocytes. Antioxidants. 12(5). 991–991. 9 indexed citations
5.
Xu, Xi, Shuo Wu, Meng Li, et al.. (2022). Risk factors for ventilator-associated pneumonia due to multi-drug resistant organisms after cardiac surgery in adults. BMC Cardiovascular Disorders. 22(1). 465–465. 8 indexed citations
6.
7.
Lao, Kejing, Ruisan Zhang, Yuxuan Dai, et al.. (2021). Identification of novel Aβ-LilrB2 inhibitors as potential therapeutic agents for Alzheimer's disease. Molecular and Cellular Neuroscience. 114. 103630–103630. 6 indexed citations
8.
Yang, Jun, et al.. (2021). Insights Into the Function and Clinical Application of HDAC5 in Cancer Management. Frontiers in Oncology. 11. 661620–661620. 26 indexed citations
9.
Xu, Xi, Chaoju Gong, Yunfeng Wang, et al.. (2020). Multi-Omics Analysis to Identify Driving Factors in Colorectal Cancer. Epigenomics. 12(18). 1633–1650. 14 indexed citations
10.
Yang, Xiaoming, Xi Xu, Xiaodong Cai, et al.. (2020). Gene set enrichment analysis and protein-protein interaction network analysis after sciatic nerve injury. Annals of Translational Medicine. 8(16). 988–988. 2 indexed citations
11.
Zhang, Junfeng, Pengbo Yang, Shengfeng Ji, et al.. (2018). MicroRNA-770 affects proliferation and cell cycle transition by directly targeting CDK8 in glioma. Cancer Cell International. 18(1). 195–195. 24 indexed citations
12.
Zhao, Yufeng, Lei Zhang, Di Chen, et al.. (2018). Grifolic acid induces GH3 adenoma cell death by inhibiting ATP production through a GPR120-independent mechanism. BMC Pharmacology and Toxicology. 19(1). 26–26. 9 indexed citations
13.
Zhang, Junfeng, Li Zhang, Lili Shi, et al.. (2017). Parthenolide attenuates cerebral ischemia/reperfusion injury via Akt/GSK-3β pathway in PC12 cells. Biomedicine & Pharmacotherapy. 89. 1159–1165. 34 indexed citations
14.
Liu, Zhenzhen, Wenhua Kuang, Xi Xu, et al.. (2017). Putative identification of components in Zengye Decoction and their effects on glucose consumption and lipogenesis in insulin-induced insulin-resistant HepG2 cells. Journal of Chromatography B. 1073. 145–153. 18 indexed citations
15.
Zhang, Junfeng, Lili Shi, Li Zhang, et al.. (2016). MicroRNA-25 Negatively Regulates Cerebral Ischemia/Reperfusion Injury-Induced Cell Apoptosis Through Fas/FasL Pathway. Journal of Molecular Neuroscience. 58(4). 507–516. 71 indexed citations
16.
Huang, Mei, et al.. (2013). Prevalence and factors related to hepatitis B and C infection in inflammatory bowel disease patients in China: A retrospective study. Journal of Crohn s and Colitis. 8(4). 282–287. 34 indexed citations
17.
Tong, Jin Lu, Mei Huang, Xi Xu, Yu Qiao, & Zhi Hua Ran. (2012). Once‐daily versus multiple‐daily mesalamine for patients with ulcerative colitis: A meta‐analysis. Journal of Digestive Diseases. 13(4). 200–207. 10 indexed citations
18.
19.
Tong, Jin Lu, Fang Nie, Xi Xu, et al.. (2011). MicroRNA 506 regulates expression of PPAR alpha in hydroxycamptothecin-resistant human colon cancer cells. FEBS Letters. 585(22). 3560–3568. 73 indexed citations
20.
Zhu, Mingming, Xi Xu, Fang Nie, et al.. (2010). Comparison of immunochemical and guaiac‐based fecal occult blood test in screening and surveillance for advanced colorectal neoplasms: A meta‐analysis. Journal of Digestive Diseases. 11(3). 148–160. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yisheng Pan Breakdown of academic impact, for papers by Srinivas Chava Breakdown of academic impact, for papers by Wen Zhou Breakdown of academic impact, for papers by Hongchun Liu Breakdown of academic impact, for papers by Li Bao Breakdown of academic impact, for papers by Yuqi He Breakdown of academic impact, for papers by Dil Afroze Breakdown of academic impact, for papers by Sung‐Chul Lim Breakdown of academic impact, for papers by Qian Ma
Rankless by CCL
2026